ANAVEX LIFE SCIENCES CORP. Deferred Tax Assets, Operating Loss Carryforwards, Foreign
ANAVEX LIFE SCIENCES CORP. (AVXL) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $76.80 million as of 2020-09-30, per its 10-K filed 2020-12-28.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2020-12-28
- 2020-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $76.80M.
- 2019-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $60.80M.
- 2018-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $50.60M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign |
|---|---|
| 2020-09-30 | $76.80M 10-K · filed 2020-12-28 |
| 2019-09-30 | $60.80M 10-K · filed 2020-12-28 |
| 2018-09-30 | $50.60M 10-K · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |